Mark Coleman - Jun 4, 2021 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/S/ Herriot Tabuteau, M.D., Attorney-in-Fact
Stock symbol
AXSM
Transactions as of
Jun 4, 2021
Transactions value $
$0
Form type
4
Date filed
6/8/2021, 04:51 PM
Previous filing
May 13, 2021
Next filing
Nov 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +7.33K $0.00 7.33K Jun 4, 2021 Common Stock 7.33K $61.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the one-year anniversary of the date of grant, June 4, 2022.